Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Rheumatoid arthritis

Pathophysiology

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Browse the hub

20-09-2021 | Rheumatoid arthritis | News

Recurrent RA joint swelling tends to affect same joints each time

Localized inflammatory factors may play a role in joint swelling among people with rheumatoid arthritis, say researchers who found that swelling tends to recur in the same joints over time.

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Visit the hub

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Visit the hub

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

3–9 November: Keep up with the latest news and interviews from the conference.

Visit the conference hub

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Read the article

08-02-2021 | Rheumatoid arthritis | News

Multiple autoantibody positivity linked to increased radiographic progression in early RA

Individuals with a wide range of anti-modified protein antibodies experience higher rates of early radiographic progression than those with just a single antibody type, show data from the Scottish Early Rheumatoid Arthritis inception cohort.

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Browse the hub

Get ready for ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Visit the conference hub

11-10-2019 | Rheumatoid arthritis | News

Lympho-myeloid pathotype linked to more aggressive disease in RA

Having a lympho-myeloid pathotype at onset of rheumatoid arthritis is associated with an increased subsequent need for biologic therapy, irrespective of clinical classification, study findings indicate.

15-08-2018 | Rheumatoid arthritis | Review | Article

Rheumatoid arthritis and the mucosal origins hypothesis: Protection turns to destruction

Holers VM et al. Nat Rev Rheumatol 2018; 14: 542–557. doi: 10.1038/s41584-018-0070-0

03-08-2018 | Pathophysiology | Review | Article

S100 proteins in rheumatic diseases

Austermann J, Spiekermann C, Roth J. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0058-9

19-06-2018 | Rheumatoid arthritis | Article

Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis

Chen YL et al. Arthritis Res Ther 2018; 20: 130. doi: 10.1186/s13075-018-1623-y

08-06-2018 | Pain | Review | Article

Cannabinoids for the treatment of rheumatic diseases: Where do we stand?

Katz-Talmor D et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0025-5

04-06-2018 | Inflammation | Review | Article

Novel insights into the role of inflammasomes in autoimmune and metabolic rheumatic diseases

Deuteraiou K et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4074-5

23-05-2018 | Rheumatoid arthritis | Article

Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis

Lauková L et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4055-8

22-05-2018 | Rheumatoid arthritis | Article

The impact of dietary habits on the pathogenesis of rheumatoid arthritis: A case-control study

Rambod M, Nazarinia M, Raieskarimian F. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4151-x

16-04-2018 | Ankylosing spondylitis | Article

Functional defects of Treg cells: New targets in rheumatic diseases, including ankylosing spondylitis

Miao J & Zhu P. Curr Rheumatol Rep 2018; 20(5): 30. doi: 10.1007/s11926-018-0729-1

More


More on rheumatoid arthritis


« Back to main page | Clinical trials | Comorbidities | Diagnosis and screening | Epidemiology | Medications | Non-pharmacologic treatment | Pathophysiology | Quality of life


Image Credits